Literature DB >> 15695821

The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling.

Annett Schoenemeyer1, Betsy J Barnes, Margo E Mancl, Eicke Latz, Nadege Goutagny, Paula M Pitha, Katherine A Fitzgerald, Douglas T Golenbock.   

Abstract

Interferon regulatory factors (IRFs) are critical components of virus-induced immune activation and type I interferon regulation. IRF3 and IRF7 are activated in response to a variety of viruses or after engagement of Toll-like receptor (TLR) 3 and TLR4 by double-stranded RNA and lipopolysaccharide, respectively. The activation of IRF5, is much more restricted. Here we show that in contrast to IRF3 and IRF7, IRF5 is not a target of the TLR3 signaling pathway but is activated by TLR7 or TLR8 signaling. We also demonstrate that MyD88, interleukin 1 receptor-associated kinase 1, and tumor necrosis factor receptor-associated factor 6 are required for the activation of IRF5 and IRF7 in the TLR7 signaling pathway. Moreover, ectopic expression of IRF5 enabled type I interferon production in response to TLR7 signaling, whereas knockdown of IRF5 by small interfering RNA reduced type I interferon induction in response to the TLR7 ligand, R-848. IRF5 and IRF7, therefore, emerge from these studies as critical mediators of TLR7 signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695821     DOI: 10.1074/jbc.M412584200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  159 in total

Review 1.  Association of MicroRNA-146a with autoimmune diseases.

Authors:  Wang-Dong Xu; Man-Man Lu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus.

Authors:  Di Feng; Rivka C Stone; Maija-Leena Eloranta; Niquiche Sangster-Guity; Gunnel Nordmark; Snaevar Sigurdsson; Chuan Wang; Gunnar Alm; Ann-Christine Syvänen; Lars Rönnblom; Betsy J Barnes
Journal:  Arthritis Rheum       Date:  2010-02

3.  Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway.

Authors:  Peihong Dai; Hua Cao; Taha Merghoub; Francesca Avogadri; Weiyi Wang; Tanvi Parikh; Chee-Mun Fang; Paula M Pitha; Katherine A Fitzgerald; Masmudur M Rahman; Grant McFadden; Xiaoyu Hu; Alan N Houghton; Stewart Shuman; Liang Deng
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

4.  Differential Toxicological Outcome of Corn Oil Exposure in Rats and Mice as Assessed by Microbial Composition, Epithelial Permeability, and Ileal Mucosa-Associated Immune Status.

Authors:  Kuppan Gokulan; Amit Kumar; Mohamed H Lahiani; Vicki L Sutherland; Carl E Cerniglia; Sangeeta Khare
Journal:  Toxicol Sci       Date:  2021-02-26       Impact factor: 4.849

5.  Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.

Authors:  Pierre Duffau; Hanni Menn-Josephy; Carla M Cuda; Salina Dominguez; Tamar R Aprahamian; Amanda A Watkins; Kei Yasuda; Paul Monach; Robert Lafyatis; Lisa M Rice; G Kenneth Haines; Ellen M Gravallese; Rebecca Baum; Christophe Richez; Harris Perlman; Ramon G Bonegio; Ian R Rifkin
Journal:  Arthritis Rheumatol       Date:  2015-12       Impact factor: 10.995

6.  Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.

Authors:  Shunbin Ning; Leslie E Huye; Joseph S Pagano
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 7.  Sex-related factors in autoimmune liver diseases.

Authors:  Dorothee Schwinge; Christoph Schramm
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

Review 8.  Sexual dimorphism in HIV-1 infection.

Authors:  Anne Rechtien; Marcus Altfeld
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

9.  Toll-like receptor 7 mediates early innate immune responses to malaria.

Authors:  Alyssa Baccarella; Mary F Fontana; Eunice C Chen; Charles C Kim
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

10.  IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Authors:  Christophe Richez; Kei Yasuda; Ramon G Bonegio; Amanda A Watkins; Tamar Aprahamian; Patricia Busto; Rocco J Richards; Chih Long Liu; Regina Cheung; Paul J Utz; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.